EUVIMEDEUVIMED entdecken
Open Access

Mechanism of an RBM-targeted rabbit monoclonal antibody 9H1 neutralizing SARS-CoV-2

Xiaoyu Chu, Xinyu Ding, Yixuan Yang, Yuchi Lu, Tinghan Li, Yan Gao, Le Zheng, Hang Xiao, Tingting Yang, Hao Cheng, Haibin Huang, Yang Liu und 6 weitere

Biochemical and Biophysical Research Communications · 2023

DOI: 10.1016/j.bbrc.2023.04.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023. Verfasst von Xiaoyu Chu und 17 weiteren Autor:innen. Beteiligte Einrichtung: The State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, 210023, China. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Jiangsu Commission of Health, Jiangsu Provincial Key Research and Development Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID-19 pandemic, caused by SARS-CoV-2, has led to over 750 million infections and 6.8 million deaths worldwide since late 2019. Due to the continuous evolution of SARS-CoV-2, many significant variants have emerged, creating ongoing challenges to the prevention and treatment of the pandemic. Therefore, the study of antibody responses against SARS-CoV-2 is essential for the development of vaccines and therapeutics. Here we perform single particle cryo-electron microscopy (cryo-EM) structure determination of a rabbit monoclonal antibody (RmAb) 9H1 in complex with the SARS-CoV-2 wild-type (WT) spike trimer. Our structural analysis shows that 9H1 interacts with the receptor-binding motif (RBM) region of the receptor-binding domain (RBD) on the spike protein and by directly competing with angiotensin-converting enzyme 2 (ACE2), it blocks the binding of the virus to the receptor and achieves neutralization. Our findings suggest that utilizing rabbit-derived mAbs provides valuable insights into the molecular interactions between neutralizing antibodies and spike proteins and may also facilitate the development of therapeutic antibodies and expand the antibody library.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansAntibodies, MonoclonalPandemicsCryoelectron MicroscopyAntibodies, ViralReceptors, VirusAntibodies, NeutralizingProtein BindingSpike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

Antibody developmentCryo-EMReceptor-binding domainRmAbSARS-CoV-2Spike protein

Substanzen

Antibodies, MonoclonalAntibodies, ViralReceptors, VirusAntibodies, NeutralizingSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • The State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, 210023, China.
  • Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, 210008, China; School of Environmental and Biological Engineering, Nanjing University of Science & Tec…
  • Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
  • Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China; Shanghai Clinical Research and Trial Center, Shanghai, 201210, China.
  • Yurogen Biosystem LLC, Wuhan, Hubei, 430075, China.
  • Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, Jiangsu, 210008, China.

Förderung

  • Jiangsu Commission of Health
  • Jiangsu Provincial Key Research and Development Program
  • National Natural Science Foundation of China
  • Key Technologies Research and Development Program
  • National Key Research and Development Program of China
  • ShanghaiTech University
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Chu, X., Ding, X., Yang, Y., Lu, Y., Li, T., Gao, Y., Zheng, L., Xiao, H., Yang, T., Cheng, H., Huang, H., Liu, Y., Lou, Y., Wu, C., Chen, Y., Yang, H., Ji, X., & Guo, H. (2023). Mechanism of an RBM-targeted rabbit monoclonal antibody 9H1 neutralizing SARS-CoV-2. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.04.002

Vancouver

Chu X, Ding X, Yang Y, Lu Y, Li T, Gao Y, et al. Mechanism of an RBM-targeted rabbit monoclonal antibody 9H1 neutralizing SARS-CoV-2. Biochemical and Biophysical Research Communications. 2023. doi:10.1016/j.bbrc.2023.04.002

BibTeX
@article{Chu2023,
  author = {Chu, Xiaoyu and Ding, Xinyu and Yang, Yixuan and Lu, Yuchi and Li, Tinghan and Gao, Yan and Zheng, Le and Xiao, Hang and Yang, Tingting and Cheng, Hao and Huang, Haibin and Liu, Yang and Lou, Yang and Wu, Chao and Chen, Yuxin and Yang, Haitao and Ji, Xiaoyun and Guo, Hangtian},
  title = {Mechanism of an RBM-targeted rabbit monoclonal antibody 9H1 neutralizing SARS-CoV-2},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2023},
  doi = {10.1016/j.bbrc.2023.04.002}
}
Kostenlos starten →